Beyond IL-1β: A Hypothesis Linking Interictal S100A12, IL-18 and Serum Amyloid A to Mast Cell and Basophil Activation as a Possible Mechanism for Interictal Symptoms in Familial Mediterranean Fever

Familial Mediterranean Fever (FMF) is a monogenic autoinflammatory disorder classically attributed to MEFV mutations, pyrin inflammasome activation, and episodic interleukin-1β (IL-1β) release. Although daily colchicine and targeted IL-1 inhibitors effectively prevent acute serositis flares in most patients, a substantial subset experiences persistent, debilitating interictal symptoms—including chronic fatigue, myalgia, arthralgia, and hypersensitivity-like manifestations—during clinically attack-free periods. Because IL-1β secretion is pulsatile, the classic paradigm may not fully explain this smoldering interictal morbidity. A recent cohort study also reported mast cell activation symptoms and elevated histamine in FMF without identifying the responsible mediators. Here, we propose a partly IL-1–independent innate effector axis linking subclinical neutrophil and hepatic activation to chronic mast cell and basophil activation. Its best-supported component is residual neutrophil-derived S100A12, which remains elevated in some colchicine-treated patients with persistent symptoms and can activate mast cells in vitro. Integrating FMF pathophysiology with mast cell biology, we hypothesize that: (1) spontaneous, Gasdermin D- and reactive oxygen species-dependent neutrophil cell death observed ex vivo in patients in clinical remission may release increased amounts of S100A12, which can activate tissue mast cells through a receptor that remains to be identified; (2) interictally elevated IL-18 (so far reported in small studies with limited genotype data) may activate circulating basophils (in the presence of IL-3) to sustain systemic histamine and Th2 cytokine release; and (3) as a more speculative amplifier that depends largely on IL-1 and IL-6, persistently elevated interictal Serum Amyloid A (SAA) may recruit mast cells through a pathway consistent with Formyl Peptide Receptor 2 (FPR2) and, more speculatively, prime them via epithelial IL-33 secretion. This tripartite mechanism could help explain part of the interictal symptom burden, particularly in patients with incomplete biochemical remission, and generates testable biomarker predictions. Mast cell–directed approaches, such as mast cell stabilizers and mediator blockers, would merit controlled evaluation only after those predictions have been tested.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24284867
Primary Topic
Inflammasome and immune disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beyond IL-1β: A Hypothesis Linking Interictal S100A12, IL-18 and Serum Amyloid A to Mast Cell and Basophil Activation as a Possible Mechanism for Interictal Symptoms in Familial Mediterranean Fever

Mehmet Ugur Ocal
1 links
Zenodo (CERN European Organization for Nuclear Research)
Inflammasome and immune disorders
preprint

Beyond IL-1β: A Hypothesis Linking Interictal S100A12, IL-18 and Serum Amyloid A to Mast Cell and Basophil Activation as a Possible Mechanism for Interictal Symptoms in Familial Mediterranean Fever

Mehmet Ugur Ocal
preprint en

Abstract

Familial Mediterranean Fever (FMF) is a monogenic autoinflammatory disorder classically attributed to MEFV mutations, pyrin inflammasome activation, and episodic interleukin-1β (IL-1β) release. Although daily colchicine and targeted IL-1 inhibitors effectively prevent acute serositis flares in most patients, a substantial subset experiences persistent, debilitating interictal symptoms—including chronic fatigue, myalgia, arthralgia, and hypersensitivity-like manifestations—during clinically attack-free periods. Because IL-1β secretion is pulsatile, the classic paradigm may not fully explain this smoldering interictal morbidity. A recent cohort study also reported mast cell activation symptoms and elevated histamine in FMF without identifying the responsible mediators. Here, we propose a partly IL-1–independent innate effector axis linking subclinical neutrophil and hepatic activation to chronic mast cell and basophil activation. Its best-supported component is residual neutrophil-derived S100A12, which remains elevated in some colchicine-treated patients with persistent symptoms and can activate mast cells in vitro. Integrating FMF pathophysiology with mast cell biology, we hypothesize that: (1) spontaneous, Gasdermin D- and reactive oxygen species-dependent neutrophil cell death observed ex vivo in patients in clinical remission may release increased amounts of S100A12, which can activate tissue mast cells through a receptor that remains to be identified; (2) interictally elevated IL-18 (so far reported in small studies with limited genotype data) may activate circulating basophils (in the presence of IL-3) to sustain systemic histamine and Th2 cytokine release; and (3) as a more speculative amplifier that depends largely on IL-1 and IL-6, persistently elevated interictal Serum Amyloid A (SAA) may recruit mast cells through a pathway consistent with Formyl Peptide Receptor 2 (FPR2) and, more speculatively, prime them via epithelial IL-33 secretion. This tripartite mechanism could help explain part of the interictal symptom burden, particularly in patients with incomplete biochemical remission, and generates testable biomarker predictions. Mast cell–directed approaches, such as mast cell stabilizers and mediator blockers, would merit controlled evaluation only after those predictions have been tested.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon